News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Eansor Norman David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Eansor Norman David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Bought 14,285 shares
@ $17.5, valued at
$250k
Gifted 14,285 shares
@ $0
Gifted 7,142 shares
@ $0
Granted 8,000 options to buy
@ $1.72, valued at
$13.8k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2021 |
4
| Eansor Norman David (President-Protein Sciences) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 700 shares
@ $504.0864, valued at
$352.9k
Sold 200 shares
@ $504.78, valued at
$101k
Sold 300 shares
@ $502.99, valued at
$150.9k
Sold 537 shares
@ $504.1437, valued at
$270.7k
Sold 400 shares
@ $505.005, valued at
$202k
Sold 4,054 shares
@ $502.7678, valued at
$2M
Sold 9,043 shares
@ $503.6091, valued at
$4.6M
Sold 8,989 shares
@ $504.3926, valued at
$4.5M
Sold 2,535 shares
@ $505.4861, valued at
$1.3M
Sold 401 shares
@ $506.2399, valued at
$203k
Exercised 27,159 options to buy
@ $125.05, valued at
$3.4M
|
|
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Eansor Norman David (President-Protein Sciences) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 3,448 shares
@ $260.1897, valued at
$897.1k
Sold 1,700 shares
@ $260.8292, valued at
$443.4k
Sold 3,400 shares
@ $261.7431, valued at
$889.9k
Sold 2,100 shares
@ $262.6759, valued at
$551.6k
Sold 709 shares
@ $264.0119, valued at
$187.2k
Exercised 3,448 options to buy
@ $108.49, valued at
$374.1k
Exercised 7,909 options to buy
@ $108.49, valued at
$858k
|
|
| 05/26/2020 |
4
| Eansor Norman David (President-Protein Sciences) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 10,137 shares
@ $267.369, valued at
$2.7M
Sold 900 shares
@ $268.885, valued at
$242k
Sold 7,676 shares
@ $267.625, valued at
$2.1M
Sold 4,924 shares
@ $268.407, valued at
$1.3M
Exercised 11,037 options to buy
@ $94.35, valued at
$1M
Exercised 3,963 options to buy
@ $94.35, valued at
$373.9k
Exercised 8,637 options to buy
@ $108.49, valued at
$937k
|
|
| 03/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2019 |
4
| Eansor Norman David (SVP - Novus Biologicals) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 900 shares
@ $197.57, valued at
$177.8k
Exercised 2,287 restricted stock units
@ $0 |
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2019 |
4
| Eansor Norman David (SVP - Novus Biologicals) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 3,117 shares
@ $215, valued at
$670.2k
|
|
| 05/13/2019 |
4
| Eansor Norman David (Director) has filed a Form 4 on Marker Therapeutics, Inc.|
Txns:
| Granted 7,260 shares
@ $0 |
|
| 10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2018 |
4
| Eansor Norman David (SVP - Novus Biologicals) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Paid exercise price by delivering 348 shares
@ $180.14, valued at
$62.7k
Exercised 1,199 restricted stock units
@ $0
Disposed/sold 301 restricted stock units
@ $0
Disposed/sold 1,881 options to buy
@ $108.49, valued at
$204.1k
Granted 2,537 restricted stock units
@ $0
Granted 18,066 options to buy
@ $177.32, valued at
$3.2M
Granted 13,550 options to buy
@ $177.32, valued at
$2.4M
|
|
| 05/11/2018 |
4
| Eansor Norman David (SVP - Novus Biologicals) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Sold 1,136 shares
@ $145.1864, valued at
$164.9k
|
|
| 10/30/2017 |
4
| Eansor Norman David (SVP - Novus Biologicals) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 2,174 restricted stock units
@ $0
Granted 11,982 options to buy
@ $125.05, valued at
$1.5M
Granted 15,976 options to buy
@ $125.05, valued at
$2M
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/22/2016 |
4
| Eansor Norman David (SVP - Biotech) has filed a Form 4 on BIO-TECHNE Corp|
Txns:
| Granted 18,819 options to buy
@ $106.59, valued at
$2M
Granted 14,114 options to buy
@ $106.59, valued at
$1.5M
Granted 2,287 restricted stock units
@ $0 |
|
| 07/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|